Countries China

Dizal's Golidocitinib Approved in China as First JAK1-Only Inhibitor for Relapsed or Refractory Peripheral T-Cell Lymphoma

Golidocitinib is a first-in-class Janus kinase 1 (JAK1) only inhibitor approved for the treatment of r/r PTCL based on results from the multinational piv...

 June 20, 2024 | News

YolTech Partners with KACTUS to Commercialize Breakthrough DNA Editor YolCas12TM in Greater China

YolTech, a clinical-stage biopharmaceutical company specializing in mRNA-LNP delivery for in vivo gene editing therapies, has partnered with KACT...

 June 19, 2024 | News

ReviR Therapeutics and Asieris Pharmaceuticals Achieve Milestone in Cancer Treatment Collaboration

ReviR Therapeutics, a biotechnology company specializing in the development of small molecule RNA splicing modulators for neurogenetic diseases and oncolog...

 June 18, 2024 | News

FDA Clears Zymeworks' ZW171 for Mesothelin-Expressing Cancers

  “We are excited to reach this R&D milestone with ZW171, reflecting our commitment to advancing innovative therapies for cancer treatment,...

 June 18, 2024 | News

Venus Medtech Achieves Milestone with First U.S. Implantation of VenusP-Valve in PROTEUS Study

Venus Medtech, a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced today th...

 June 17, 2024 | News

Ascentage Pharma Secures $1.3 Billion Deal with Takeda for Global Rights to Olverembatinib

Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas. ...

 June 17, 2024 | News

Ethypharm Expands Portfolio with Acquisition of Mesalazine Suppository by Chinese Affiliate

Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate, Shanghai Ethypharm Pharmaceuticals Ltd, from...

 June 14, 2024 | News

Zymeworks Secures $8 Million Milestone Payment and Advances Cancer Treatment with FDA and NMPA Approvals

Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from Bei...

 June 11, 2024 | News

Xiao-I Corporation Secures Major Contract with Multinational Health Tech Conglomerate to Revolutionize Knowledge Management

Xiao-I Corporation , a leading AI company, announces a contract is secured from a renowned multinational conglomerate in the health technology sector base ...

 June 07, 2024 | News

Shanghai MicuRx Achieves Key Milestone in Combatting Drug-Resistant Infections with Successful Phase I Trial of MRX-8

According to the World Health Organization (WHO), millions of patients face treatment difficulties or even life-threatening conditions due to resistant b...

 June 07, 2024 | News

OBiO Technology Launches Clinical Evaluation and Translation Center for Pediatric Rare Diseases

OBiO Technology, a world leading contract development and manufacturing organization for cell and gene therapy, officially launched the "Center f...

 May 31, 2024 | News

Kexing Biopharm’s Subsidiary Receives Approval for Clinical Trials of Innovative GB08 Growth Hormone

Kexing Biopharm announced that Shenzhen Kexing Pharmaceutical Co., Ltd., its wholly-owned subsidiary, recently received a Notice of Approval for Drug Clini...

 May 31, 2024 | News

HuidaGene Therapeutics and Synthego Corporation Forge Licensing Agreement for Advanced CRISPR Nuclease

HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corpo...

 May 31, 2024 | News

Innovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to SevereInnovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to Severe Plaque Psoriasis

Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of canc...

 May 28, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close